Page 20 - AWA Vol.41-No.2

ANIMAL HEALTH

Forever Feed Technologies Completes the World's

Largest Automated Sprouted Grain Feed Mill
he FFT Feed Mill has begun growing ASG (Automated
TSprouted Grain) that will supplement dairy and beef cattle
feed using a fraction of the water needed for field grown alfalfa.
Forever Feed Technologies announced the completion of the
FFT Innovation Center on River Ranch Farms in Hanford, Cali-
fornia, housing the world's largest Automated Sprouted Grain
(FFT-ASG™) feed mill. The Innovation Center feed mill pro-
duces fresh ASG daily to supplement feed rations for dairy and
beef cattle, using a small fraction of the water that's needed for
field-grown alfalfa. The FFT Innovation Center feed mill is the
first phase of a commercial scale version that is targeted to grow
up to 50 tons of ASG per-day, reducing on-farm risks due to
droughts and severe weather conditions, and will move opera-
tors closer to their 2030 Net-Zero sustainability goals.
Ranch Farms. "Just one commercial scale feed mill will add fresh
The design of the FFT Feed Mill began in 2022 when Forever feed to the daily diet of more than 2,500 dairy cows. Our plan is
Feed engaged JR Automation, a Hitachi, Ltd. company, to help to start building these mills as early as this year."
integrate time-test material handling technology with FFT's pat-
ent pending indoor growing protocols. The robust capabilities Farmers know that the health of their livestock improves and
of material handling systems and FFT's proprietary methods production increases by incorporating fresh feed into the ani-
make the feed mill dependable enough to support the high de- mals' diet. But there has never been an indoor sprouted grain
mands of supplying fresh feed year-round on major dairy and feed mill large enough to prove these year-around benefits on
beef operations. a commercial scale…or dependable enough to feed thousands
"Completing the Innovation Center is a milestone that will en- of cows daily. The new Forever Feed Innovation Center will help
able us to refine the mechanical systems and protocols needed farmers understand the economics and sustainability impacts
to build our larger commercial scale feed mills," said Jack de of the FFT Feed Mill to help them meet the growing demand for
Jong, CEO of Forever Feed Technologies, and owner of River dairy and beef products. Circle 26 on enquiry card

Ceva Animal Health Inaugurates Biogenovac,

A State-Of-The-Art Genomics Laboratory

eva Animal Health (Ceva), the world’s fifth-largest animal
Chealth company, inaugurates Biogenovac, its brand-new
genomics research laboratory, in Beaucouzé (Maine-et-Loire),
France. The laboratory, which is partly financed by the French
government as part of its recovery plan and the Pays de la Loire
region, reinforces Ceva’s commitment to preventing future
health crises by anticipating variations in viral strains and com-
bating emerging animal diseases.
Innovative technologies to design and produce the vaccines of
the future to combat emerging diseases
Responding to the challenges posed by the rise of new epizoot-
ics, this new technological platform will enable Ceva to develop
effective, industrialized, and competitive vaccine solutions ca-
pable of rapidly responding to the rise of emerging infectious
diseases. Present in 47 countries with 21 R&D centres across the globe,
With this investment, Ceva confirms its leadership in animal Ceva is deeply attached to global health and industrial sover-
health research and innovation and its commitment to the One eignty and plays an active role in it investing 10% of its turnover
Health concept. annually into R&D endeavours. This initiative is a unique oppor-
tunity to develop effective, safe and scientifically innovative re-
This new platform is equipped with cutting-edge technological sponses to the major diseases affecting our livestock.
innovations incorporating the latest high-throughput sequenc-
ing and bioinformatics techniques for developing nucleotide Commenting on the inauguration, Marc Prikazsky, Chairman
vaccines: and CEO of Ceva Animal Health, said: “The inauguration of Bi-
ogenovac is a decisive step for Ceva and our ability to continue
The site boasts a centralized bioinformatics interface facilitat- innovating for the future of animal vaccination. This project tes-
ing the detailed analysis and processing of a large volume of tifies to our determination to support breeders by developing
vaccine data (coverage, efficacy, antigen design, etc.). This will tailor-made solutions to emerging diseases. This investment
enable vaccines to be adapted as closely as possible to the re- also embodies our commitment to the dynamism of our regions
alities of the field, thereby enhancing their effectiveness. and to our health and industrial sovereignty.” Circle 27 on enquiry card

18 Vol. 41 No. 2